Sign In to Follow Application
View All Documents & Correspondence

Analyte Assaying By Means Of Immunochromatography With Lateral Migration

Abstract: The invention relates to a device for determining an analyte in a liquid sample. The inventive device consists of: a capillary action means (1), involving lateral migration, defining a reference capillary action direction and comprising a liquid sample deposit area (3) and an analyte-detection area (5) which is disposed downstream of the deposit area; a first analyte-specific binding reagent (4) which is conjugated to a visible and/or measurable marker and which is free to migrate when wet by means of capillary action in the above-mentioned capillary action means (1) along the reference direction; and a second analyte-specific binding reagent (6) which is immobilised in the detection area. The invention is characterised in that the detection area (5) comprises the analyte (7) or an analogue of the analyte, which is immobilised and disposed at a distance from the second specific binding reagent (6).

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
14 February 2008
Publication Number
46/2008
Publication Type
INA
Invention Field
MECHANICAL ENGINEERING
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2018-07-25
Renewal Date

Applicants

VEDALAB
ZAT DU LONDEAU RUE DE 1'EXPANSION-CERISE 61000 ALENCON

Inventors

1. DONATI RAPHAËL
4 RUE D'ECOUVES 61250 RADON

Specification

Analyte assaying by means of immunochromatography with lateral migration
The present invention relates to an immunochromatography device with
lateral migration enabling simultaneous determination of an analyte in a liquid
sample using a sandwich test and using a competition test.
Immunochromatographic devices with lateral migration are described, for
example, in patent EP 0 284 232. These devices implement a capillary action
means in the form of a porous solid support within which the sample and reagents
migrate by capillary action. These devices thus integrate or comprise a porous
solid (or immunochromatographic) support comprising a first supporting area in
lyophilized, dry or dehydrated form, an analyte-specific binding reagent conjugated
to a visible and/or measurable marker, and a detection area whereon is
immobilized an analyte-specific capture reagent. The analyte-specific binding
reagent is immobile when dry, but becomes mobile in the solid support when wet.
Thus, when the solid support is put in contact with a liquid sample, the latter
migrates by capillary action in this support, driving the analyte-specific binding
reagent conjugated to the visible and/or measurable marker. The sample and the
analyte-specific binding reagent migrate by capillary action in the solid support to
the detection area bearing the immobilized analyte-specific capture reagent.
One knows from WO 2004/088320 immunochromatographic methods in
solid phase in which the binding reagent, conjugated to a visible and/or
measurable marker, is extemporaneously added in liquid form.
These devices traditionally enable detection of the analyte, either by a
sandwich test or a competition test.
In a sandwich test, the marked binding reagent binds to the analyte, and the
latter is immobilized on the solid support by the capture reagent. The presence or
absence of the analyte in the sample is measured by the presence or absence of a
visible or measurable signal, at the level of the capture reagent.
In a competition test, the analyte and the binding reagent are in competition
to bind to the capture reagent. The presence or absence of the analyte in the
2

sample is measured by the absence or presence of a visible or measurable signal,
at the level of the capture reagent.
Patents EP 0 291 194, EP 0 560 411 and EP 0 560 410 describe devices
wherein the immunochromatographic solid support in only one part is incorporated
into a case provided with an opening for depositing of the liquid sample, and an
observation window to read the result.
Patent EP 1 091 808 describes improved devices also comprising a porous
solid support in several parts, with a capture member for the liquid sample, mobile,
allowing better-collection of the sample.
These devices can be adapted for a single and at-home usage. Indeed,
they are easy and quick to use, requiring very little manipulation since all of the
reagents are integrated or comprised in the device.
However, these immunochromatographic tests in solid phase do not make it
possible to determine the quantity of the analyte in the sample.
Moreover, in the sandwich test, for some analytes a "hook" effect has been
observed. The hook effect is a well-known undesirable effect in immunological
tests. It occurs when the analyte is present in the sample at a very high
concentration. The hook effect can then lead to false negatives, erroneously
concluding the absence of the analyte in the sample.
The analytes which present a hook effect during sandwich-type
immunological assays have signal/concentration curves of the Gauss curve type
(see figure 1). Figure 1 shows that to a given signal (S) correspond two possible
concentrations of the analyte (C1 and C2), one weak (C1) and the other strong
(C2) during reading of the result at a defined time.
The signal/concentration curves for assays using competition are shown in
figure 2. For a competition test, two different signals (S1 and S2) are obtained for
two different respective concentrations (C1 and C2) of the analyte to be assayed.
However, competition tests also reveal their limitations very quickly, as the
signal becomes extinct at relatively low concentrations of the analyte.
3

One solution commonly adopted to resolve these drawbacks of sandwich
and competition tests consists of assaying the analyte, from a dilution series of the
liquid sample. The use of a dilution series is not, however, appropriate for at-home
usage. Moreover, usage of a dilution series of the sample requires additional
manipulation and increased consumption of single-use test devices, since each
sample is tested several times at different dilutions.
According to document DE 10054093, one proposes an immuno-filtering
device made up of two distinct or independent parts, assigned to a sandwich-type
test and a competition-type test, respectively. With this device, a specific binding
reagent conjugated to a fluorescent marker is extemporaneously mixed with the
analyte. The mixture obtained is then divided into two portions. A first portion is
filtered in the sandwich part, and reacts with a second binding reagent,
immobilized, and a second portion is filtered in the competition part of the device,
and reacts with a capture reagent which is immobilized and identical to the
analyte, or an analogue of the analyte. The fluorescent signals respectively
obtained make it possible to determine the analyte.
This device is not of a nature to improve the sensitivity or precision of
determination of the analyte, as each elementary test works with the initial
concentration of the specific binding reagent.
According to document US 2005/0112729 (cf. in particular paragraph 0063
and claim 1), one describes a device for determining a complex between an
analyte and a first specific binding reagent which is marked, this device
comprising:
- a capillary action means,
- in one so-called competition area of the capillary action means, a second
analyte-specific binding reagent, which is immobilized and complexed with a
ligand, also marked,
- a so-called detection area of the capillary action means, a capture reagent
which is immobilized and able to bind itself both to the aforementioned complex
and the marked ligand, the latter being able to be displaced or decomplexed in the
competition area by the circulation of said complex on the capillary action means.
4

Determination of the analyte is obtained from signals obtained in the
competition and detection areas.
The format of this test is complex to implement, and is justified only for
high-precision determination of the analyte.
The present invention aims to resolve the drawbacks of the previously
discussed devices. In particular, the present invention relates first to a test device,
and also to a usage method of the latter, allowing determination of the analyte,
with a sufficient degree of reliability and/or precision, in all circumstances, i.e.
regardless of the initial concentration of said analyte, in particular when this
concentration is relatively strong or relatively weak.
According to the invention, in reference to figure 3, one proposes a device
for determining an analyte in a liquid sample, comprising:
- a capillary action means 1, involving lateral migration determining a
reference capillary action direction 2, comprising a liquid sample deposit area 3,
and an analyte detection area 5 which is disposed downstream of said deposit
area,
- a first analyte-specific binding reagent- 4, conjugated to a visible and/or
measurable marker, and which is free to migrate when wet by means of capillary
action, in the above-mentioned capillary action means 1, along the reference
direction,
- a second analyte-specific binding reagent 6 which is immobilized in the
detection area 5,
characterized in that the detection area 5 comprises the analyte, or an analogue of
the analyte, which is immobilized and disposed at a distance from the second
specific binding reagent 6.
This device preferably has one or several of the following secondary
characteristics, considered alone or in combination, still explained in reference to
figure 3:
- this device may comprise a liquid sample capture member, independent of
the capillary action means, able to be brought into contact with the deposit area,
for circulation of said sample into said deposit area.
5

- the capillary action means 1 may comprise an area for disposing the first
binding reagent 4, in the dry and free state, in or on said capillary action means;
the area for disposing the first binding reagent is merged with the deposit area of
the sample, or is disposed downstream of the latter, but upstream of the detection
area 5.
- in the detection area 5, the analyte 7, or the analogue of the analyte, is
disposed upstream or downstream of the second specific binding reagent.
- the second specific binding reagent 6, and/or the analyte 7, or the
analogue of the analyte, are disposed for example on the capillary action means
along a line transverse to the reference direction.
- the capillary action means can comprise a control area (C), downstream of
the detection area 5.
According to the present invention, the term "capillary action means" refers
to any means constituting or acting as a continuous capillary action unit, by lateral
migration (i.e. which is perpendicular to the thickness of the capillary material(s)
implemented for capillary action). One such capillary action means is, for example,
an oblong support along the direction and/or path of the capillary action (lateral
migration), made up of a single and same capillary or porous material, or by
several different capillary elements or materials, arranged in relation to each other,
for example overlapping, to obtain a continuity of capillary circulation from one
element or material to another, along the direction of capillary action.
A capillary action means of this type determines a direction and/or path of
capillary action for all liquid which is received or deposited at one end, toward the
other end of said means.
The capillary, or immunochromatographic by lateral migration, action
considered according to the present invention must be distinguished from that
implemented in immuno-filtering techniques, according to which the liquids
permeate the thickness of the porous filtration materials.
According to the present invention, the analyte, or the analogue of the
analyte being considered, forms the third reagent, in addition to the first and
second binding reagents. This third reagent is fixed or immobilized in the detection
area, using any suitable means. This third reagent on the capillary action means is
6

available to react specifically with the first specific binding reagent, to the exclusion
of all other entities. In particular, once deposited on the capillary action means, it is
not complexed with any other entity, or reagent, for example conjugated to a
visible and/or measurable marker.
A device of this type may be implemented according to the method or
usage form defined below, in reference to figure 3:
- the liquid sample is deposited in the deposit area of the capillary action
means,
- a sufficient time is allowed to pass for the migration by capillary action of
the liquid sample to the detection area 5,
- one observes, in the detection area, the extent to which, on one hand the
specific binding reagent 4 complexed with the analyte attaches itself to the second
specific binding reagent 6, obtaining a first signal, and on the other hand the first
non-complexed binding reagent attaches itself to the analyte 7, or the analogue of
the analyte, obtaining a second signal,
- the analyte is determined from the first and second signals.
Preferably, according to the invention, the quantity of the first binding
reagent 4 is greater than the quantity of the analyte present in the liquid sample, or
the number of complexing sites with the first binding reagent, present in said liquid
sample.
In a qualitative mode, a weak analyte concentration is detected by the
absence of the first signal and the presence of the second signal; and a significant
analyte concentration is detected by the absence of both signals. A normal analyte
concentration is detected by the presence of the first and second signals.
Advantageously, the devices and/or methods according to the present
invention make it possible to assay analytes weakly or very strongly concentrated
in a sample without obtaining false positive or false negative results. Moreover,
surprisingly, the devices and/or methods according to the present invention allow
quantitative assaying of the analyte.
7

The devices and/or methods according to the invention are particularly well-
suited to assaying of analytes presenting a significant hook effect such as the
pregnancy hormone (hCG), C-reactive protein, albumin, etc.
Description of the Invention
The present invention therefore relates to a device for determining an
analyte in a liquid sample, comprising a capillary action means (1) comprising, in
the direction of capillary action (2):
a) a sample deposit or reception area (3);
b) an analyte-specific binding reagent conjugated to a visible and/or
measurable marker, and which is free to migrate by capillary action when wet in
the capillary action means (1);
c) an analyte-detection area (5);
wherein the analyte detection area (5) comprises, successively, in the
direction of capillary action (2), on one hand a second, immobilized analyte-
specific binding reagent (6), and on the other hand the immobilized analyte (7), or
an analogue of the analyte; such that the first analyte-specific binding reagent (4)
and the second analyte-specific binding reagent (6) make it possible to determine
the analyte in the liquid sample by a sandwich test, whereas the first analyte-
specific binding reagent (4) and the immobilized analyte (7), or analogue of the
analyte, allow determination of the analyte in the liquid sample using a competition
test.
In one embodiment, the first analyte-specific binding reagent (4),
conjugated to a visible and/or measurable marker, is deposited dry on the support,
and the invention therefore relates to a device for determining an analyte in a
liquid sample comprising a capillary action means (1) comprising, in the direction
of capillary action (2):
a) a sample deposit area (3);
8

b) a first analyte-specific binding reagent (4), conjugated to a visible
and/or measurable marker, deposited dry and free to migrate when wet in the
capillary action means (1);
c) an analyte-detection area (5);
wherein the analyte-detection area (5) comprises, successively, in the direction of
capillary action (2), a second analyte-specific binding reagent (6), immobilized,
and the analyte (7), or an analogue of the analyte, immobilized; such that the first
analyte-specific binding reagent (4) and the second analyte-specific binding
reagent (6) enable determination of the analyte in the liquid sample by a sandwich
test, while the first analyte-specific binding reagent (4) and the analyte (7), or the
analogue of the analyte, immobilized, enable determination of the analyte in the
liquid sample by a competition test.
In another embodiment, the first analyte-specific binding reagent (4),
conjugated to a visible and/or measurable marker, is extemporaneously added in
the form of a reagent in liquid form.
The term "reagent in liquid form" refers to any reagent in which the binding
reagent is in a solution or suspension. Preparation of the binding reagent
conjugated to the visible and/or measurable marker in liquid form is done
according to the techniques described in the literature. Typically, the conjugated
binding reagent is in a solution or suspension in a buffered saline solution. This
solution may also include stabilizing agents and other compounds, for example
anti-bacterial or antifungal. Such stabilizing agents include, for example, bovine
albumin serum (BSA) and casein.
In some methods according to the present invention, a thinner is used when
the liquid sample is plasma, serum or whole blood, for example. This thinner
migrates in the solid support driving the sample, and the marked binding reagent.
Typically, this thinner is made up of a buffered saline solution, and may also
comprise a detergent or any other component necessary for the reaction.
Preferably, the first analyte-specific binding reagent (4) is conjugated to a
specific marker.
9

Preferably, the capillary action means (1) is a chromatographic test strip
fixed on a rigid support.
In one preferred embodiment, the capillary action means (1) is integrated
into a gripping support (8) provided with at least one observation window (9)
making it possible to observe the detection area (5).
The term "binding reagent" refers to any chemical, biochemical or biological
entity of a nature to bind specifically with the analyte, or with the capture reagent in
competition with the analyte.
The terms "bind" and "binding" refer to any strong bond, for example
covalent, or any weak bond, for example of the antigen/antibody or
avidin/streptavidin type.
The binding reagent is, for example, an antibody, antigen or nucleic acid.
In a competition test, the binding reagent is in the solid phase and fixed to
the analyte itself or a suitable analogue of the analyte. "Suitable analogue of the
analyte" refers to any entity binding specifically to the first analyte-specific binding
reagent, in competition with the analyte.
In a sandwich-type test, the first marked binding reagent is an anti-analyte
conjugated to a visible and/or measurable marker, for example a specific antibody
of the analyte, conjugated to said marker.
In a sandwich-type test, the second binding reagent binds specifically to the
analyte. The second marked binding reagent is therefore also an anti-analyte, for
example a specific antibody of the analyte conjugated to a visible and/or
measurable marker.
The term "visible and/or measurable marker" refers to any marking method
allowing direct or indirect detection by the naked eye, or with the help of an
apparatus, due to the emission of a signal, said signal being, for example, a
fluorescence, coloring, presence of an isotope, or a magnetic signal. For example,
one can cite specially colored markers such as colloidal gold, or fluorescents,
particles of colored latex, particles of fluorescent latex and particles conjugated to
avidin and streptavidin.
10

The present invention therefore concerns a device for determining an
analyte in a liquid sample, comprising a capillary action means (1), comprising, in
the direction of capillary action (2):
a) a sample deposit or reception area (2);
b) a first specific antibody of the analyte (4), conjugated to a visible
and/or measurable marker, and which is free to migrate by capillary action when
wet in the capillary action means (1);
c) an analyte-detection area (5);
device wherein the analyte-detection area (5) comprises, successively, in the
direction of capillary action (2), on one hand a second specific antibody of the
analyte (6), immobilized, and on the other hand the analyte (7), or an analogue of
the analyte, immobilized; such that the first analyte-specific antibody (4) and the
second analyte-specific antibody (6) enable determination of the analyte in the
liquid sample through a sandwich test, while, one on hand the first analyte-specific
antibody (4), and on the other hand the analyte (7), or the analogue of the analyte,
immobilized, enable determination of the analyte in the liquid sample through a
competition test.
In one embodiment, the first analyte-specific antibody (4), conjugated to a
visible and/or measurable marker, is deposited dry on the support, and the
invention then concerns a device for determining an analyte in a liquid sample,
comprising a capillary action means (1), and comprising, in the direction of
capillary action (2):
a) a sample deposit or reception area (3);
b) a first analyte-specific antibody (4), conjugated to a visible and/or
measurable marker, deposited dry and which is free to migrate through capillary
action when wet in the capillary action means (1);
c) an analyte-detection area (5);
device wherein the analyte-detection area (5) comprises, successively, in
the direction of capillary action (2), on one hand a second analyte-specific
antibody (6), immobilized, and on the other hand the analyte (7), or an analogue of
11

the analyte, immobilized; such that the first analyte-specific antibody (4) and the
second analyte-specific antibody (6) enable determination of the analyte in the
liquid sample through a sandwich test, while, on one hand the first analyte-
specific antibody (4), and on the other hand the analyte (7), or the analogue of the
analyte, immobilized, enable determination of the analyte in the liquid sample
through a competition test.
In another embodiment, the first analyte-specific antibody (4), conjugated to
a visible and/or measurable marker, is extemporaneously added in the form of a
reagent in liquid form.
Preferably, the first analyte-specific antibody (4) is conjugated to a visible
and/or measurable marker.
Preferably, the capillary action means (1) is a chromatographic test strip
fixed on a rigid support.
In one preferred embodiment, the capillary action means (1) is integrated
into a gripping support (8) provided with at least one observation window (9)
making it possible to observe the detection area (5).
The invention also concerns a method for determining an analyte in a liquid
sample, implementing a device as previously defined, comprising the following
steps:
a) one has at least one capillary action means provided with at least
one deposit or reception area, and a detection area, at least one capture reagent
being immobilized in the detection area,
b) one deposits, separately in the deposit area of the capillary action
means, the liquid sample at least once,
c) one waits a sufficient time for the migration through capillary action
of the liquid sample to the area comprising the first specific binding reagent,
conjugated to a visible and/or measurable marker,
d) one waits a sufficient time for the migration through capillary action
of the first specific binding reagent conjugated to a visible and/or measurable
marker and of the liquid sample to the detection area,
12

e) one observes the extent to which the specific binding reagent
conjugated to a visible and/or measurable marker fixes itself in the detection area,
to determine the analyte simultaneously through a sandwich test and a
competition test.
According to one embodiment, the first specific binding reagent conjugated
to a visible and/or measurable marker is deposited, dry and free, in or on the
porous solid support.
According to one embodiment, the first specific binding reagent conjugated
to a visible and/or measurable marker is extemporaneously added, in the form of a
reagent in liquid form, simultaneously, after or before depositing of the analyte.
According to one embodiment, a thinner in liquid form is also added or
deposited on the porous solid support.
According to one embodiment of the method, during step a), the detection
area comprises at least two capture reagents, one of the two being the
immobilized analyte or an analogue of the analyte, and the other of the two being
an immobilized analyte-specific binding reagent.
The term "capture reagent" refers to any chemical, biochemical or biological
entity of a nature to bind specifically with the analyte, or an analogue of the
analyte.
In the case of a competition test, the capture reagent also binds to the first
binding reagent. The analyte and the capture reagent typically form a ligand/anti-
ligand, antigen/antibody, DNA/RNA or DNA/DNA pair. Thus, if the analyte is an
antigen or a hapten, the capture reagent is, for example, a specific antibody of the
analyte. If the analyte is an antibody, the capture reagent is the antigen recognized
by the antibody or an antibody specifically recognizing the analyte. If the analyte is
a nucleic acid, the capture reagent is for instance a complementary DNA probe.
The immobilized capture reagent is, for example, a polyclonal or
monoclonal antibody having a strong affinity for the analyte, and more particularly
it may be a monoclonal antibody.
13

To increase sensitivity, one may use, for example, an antibody marked
according to techniques known by those skilled in the art for indirect detection,
such as for example a biotinyl antibody, indirectly enabling detection through the
formation of avidin-biotin and streptavidin-biotin entities.
These marked and biotinyl antibodies can also either be already directly
deposited on a test-line, in the detection area, to increase sensitivity, or be
deposited with the first specific antibody and be eluted and fixed such that the
analyte and the antibody increase the contact time and again sensitivity in
particular, for example, due to the number of fixing sites.
The analyte-specific capture reagent is immobilized on the solid support
according to techniques known by those skilled in the art. This capture reagent is
immobilized such that it is not mobile when wet. This immobilization can be done
for example through absorption or by covalent coupling.
The term "anti-analyte" refers to any chemical, biochemical or biological
entity of a nature to bind itself specifically with the analyte, or with the capture
reagent, in competition with the analyte, for example an antibody, antigen or
nucleic acid.
According to one embodiment, the invention also concerns a method for
determining an analyte in a liquid sample, comprising the following steps:
a) one has a device as previously described;
b) one deposits a liquid sample in the deposit or reception area (3) of
the capillary action means (1) of the device from step (a);
c) one waits a sufficient time for the migration by capillary action of the
liquid sample from the deposit or reception area (3) to the detection area (5),
driving the first analyte-specific antibody, conjugated to a visible and/or
measurable marker (4);
d) one observes the extent to which the first analyte-specific antibody
conjugated to a visible and/or measurable marker (4) is fixed in the detection area
(5), to determine the analyte, simultaneously by a sandwich test and a competition
test. In one advantageous embodiment, in step b) one deposits a liquid sample
14

and a thinner in the deposit or reception area (3) of the capillary action means (1)
of the device from step (a).
The term "analyte" refers to any chemical, biochemical or biological entity
which one wishes to detect in a sample. Among the analytes detected by the
devices and methods according to the present invention, are in particular proteins,
peptides, antibodies, hormones, steroids, antigens derived from infectious agents
or tumoral cells, infection agents such as bacteria, viruses or parasites, nucleic
acids (DNA or RNA), therapeutic compounds, drugs or antibiotics.
The terms "detect" and "determine" refer to the determination of the
presence or absence of an analyte in a sample, but also the measurement and
quantification of an analyte in a sample. Indeed, the performances of the devices
and methods according to the invention allow one to perform quantitative or semi-
quantitative measurements.
In one particular embodiment of the invention, the analyte is hCG
(choriogonadotropin hormone), C-reactive protein or albumin.
The term "liquid sample" refers to any sample wherein the analyte sought is
in a solution or suspension. This liquid sample may in particular be any biological
or bodily fluid. The liquid sample may also have been obtained directly or indirectly
from a biological or bodily fluid. The sample can also be a liquid extract of a solid
sample.
Typically, the liquid sample is urine, whole blood, plasma or serum.
In some methods according to the present invention, a thinner is used when
the liquid sample is plasma, serum or whole blood for example. The thinner is
deposited on the porous solid support with the sample. Alternatively, the thinner is
deposited on the porous solid support before or after the sample. This thinner
migrates in the solid support, driving, or facilitating the migration of the sample in
the porous support, with the marked binding reagent. Typically this thinner is made
up of a buffered saline solution; it may also comprise a detergent or any other
component necessary for the reaction.
The term "capillary action means" refers to a porous solid support allowing
the migration of a liquid by simple capillary action. The porosity of this support
15

enables the capillary action (or lateral migration) of the liquid or wet sample and/or
reagents. Such capillary action means are very widely used in all
immunochromatography techniques with lateral migration, in particular.
Thus, the capillary action means implemented in the
immunochromatographic devices according to the invention are well known by
those skilled in the art (cf. EP 0 284 232). As an example, these capillary action
means can be made up of various immunochromatographic supports, for example
cellulose, nylon, nitrocellulose, polyethylene or glass fiber.
The capillary action means may be made up of one or several distinct parts.
The various parts of the support can be made up of different materials. When the
capillary action means is made up of different parts or different materials, these
elements are disposed so as to enable continuity of capillary circulation in the
capillary action means.
Typically, the capillary action means is made up of an oblong porous solid
support along the direction of capillary action. Preferably, the capillary action
means of the devices according to the invention comprises a porous solid support
in the form of an immunochromatographic test strip. The capillary action means is
present for example in the form of an immunochromatographic test strip made up
of several superimposed or overlapping test strips.
The device according to the invention may, for example, be made up of a
chromatographic test strip fixed on a rigid support. The rigid support may be made
of various materials such as cardboard, plastic-coated cardboard or, most
preferably, plastic materials. Preferably, the rigid support is made of polystyrene.
The capillary action means comprises a sample deposit or reception area,
and a sample detection area. The deposit area and the detection area are distinct
and separate from the capillary action means. These areas are disposed so as to
allow the continuity of the capillary action from the deposit or reception area, to the
detection area along a direction of capillary action. Typically, the deposit area and
the detection area correspond respectively to the two opposite ends of the
capillary action means. The capillary action means is thus, for example, made up
of an oblong porous solid support along the direction of capillary action, having a
16

proximal end and a distal end respectively forming the deposit area and the
detection area.
These areas may, for example, be present on a same strip made of a single
material. Advantageously, a specific porous material corresponds to each area of
the capillary action means. A porous absorbent material can, for example, be used
for the sample deposit area. Indeed, the deposit area of the capillary action means
is intended to be put into contact with a flow of urine or to receive a liquid sample.
One will therefore choose a suitable absorbent material. These materials are well
known by those skilled in the art. And another absorbent material can be
implemented for the area receiving the first specific binding reagent, and/or the
detection area.
The sample deposit area of the capillary action means can cooperate with a
capturing member in an absorbent material. This capture member can be put into
direct contact with a flow of urine, for example. As described in WO 00/00288, the
capture member can be mobile between two positions, one for collecting the liquid
sample, at a distance from the capillary action means, and the other in continuity
or capillary contact with the deposit area of the capillary action means.
The capillary action means bears, for example, a first analyte-specific
antibody conjugated to a visible and/or measurable marker. This antibody is
deposited dry in the capillary action means, and is free to migrate by capillary
action when wet. This first analyte-specific antibody can be localized in the sample
deposit or reception area. This first antibody can also, however, be deposited dry,
downstream of the sample deposit or reception area, to avoid any loss of reagent
through a washing effect upon depositing of the sample. Thus, the liquid sample is
deposited in the deposit area of the capillary action means, then this sample
migrates by capillary action through the capillary action means, then driving the
first analyte-specific antibody conjugated to a marker.
Advantageously, the capillary action means can be incorporated into a
gripping support. This gripping support facilitates manipulation of the capillary
action means, and can also protect it, in particular from moisture.
17

The gripping support can partially or completely surround the capillary
action means.
The gripping support can be formed from various materials such as
cardboard, plastic-coated cardboard or, more preferably, plastic materials.
Advantageously, the gripping support is made of a rigid and impermeable material.
These gripping supports or cases are described in particular in patents EP 0 291
194, EP 0 560 411, EP 0 560 410 and EP 1 091 808.
The gripping support is usually in the form of a case.
In one embodiment of the invention, the capillary action means can
comprise a sample deposit or collection area, protruding in relation to the gripping
support, for receiving the liquid sample.
In another embodiment of the invention, the gripping support or the case
comprises at least one opening for depositing the liquid sample.
Typically, the gripping support is also provided with at least one observation
window to observe the detection area of the capillary action means.
The reagents implemented in the methods according to the present
invention, enabling the determination of the analyte in the liquid sample, are well
known by those skilled in the art.
The first analyte-specific antibody, conjugated to a visible and/or
measurable marker, is deposited dry in or on the capillary action means, but it is
free to migrate by capillary action when wet.
The second analyte-specific antibody is permanently immobilized in the
detection area of the capillary action means.
The term "analyte-specific antibody" refers to an antibody capable of
binding specifically with the analyte in an antigen/antibody type bond. It typically
involves a polyclonal or monoclonal antibody having a strong affinity for the
analyte. Preferably, it involves a monoclonal antibody.
The second analyte-specific antibody is immobilized in the detection area of
the capillary action means according to techniques known by those skilled in the
art.
18

This second antibody is immobilized such that it is not mobile when wet.
This immobilization can be done for example by absorption or covalent coupling.
The first and second antibodies bind respectively and specifically with the
analyte, for example on two epitopic sites, identical to or different from the analyte.
The first and second antibodies of the devices of the present invention
enable determination of an analyte in the liquid sample through a sandwich test.
Moreover, the devices according to the present invention comprise the
analyte itself, or an analogue of the analyte, immobilized in the detection area of
the capillary action means.
The analyte, or the analogue of the analyte, is immobilized in the detection
area of the capillary action area according to techniques known by those skilled in
the art. The analyte, or the analogue of the analyte, is immobilized such that it is
not mobile when wet. This immobilization can be done for example by absorption
or by covalent coupling.
This second reagent of the detection area is identical to the analyte itself or
a suitable analogue of the analyte. The term "suitable analogue of the analyte"
refers to any entity binding itself specifically to the first binding reagent or specific
antibody of the analyte, in competition with the analyte.
In one embodiment, on one hand, the first analyte-specific antibody,
conjugated to a visible and/or measurable marker, and on the other hand the
analyte, or the analogue of the analyte, immobilized in the detection area of the
capillary action means, enable detection of the analyte of the liquid sample
through a competition test. Preferably, the second analyte-specific antibody can be
deposited upstream of the analyte, or of the analogue of the analyte, relative to the
direction of capillary action.
The first analyte-specific antibody, which is free to migrate when wet, is
conjugated to a visible and/or measurable marker, enabling measurement or direct
observation of the result, of both the sandwich test and the competition test. Any
visible marker can be observed directly by the naked eye when it is concentrated
in the detection area of the capillary action means. Measuring the marker can be
19

done directly by the naked eye, or with the help of a measuring device. This
measurement is done by direct observation not requiring additional manipulation.
Advantageously, the devices according to the present invention comprise a
first analyte-specific antibody conjugated to a visible and/or measurable marker.
The markers used according to the present invention enable direct
detection by the naked eye, or indirect detection with the help of an apparatus, due
to the emission of a signal, said signal being for example a fluorescence, coloring,
present of isotope, magnetic signal.
One can cite, for example, particular makers, colored or fluorescent, made
up of small particles insoluble in water and which therefore form suspensions,
dispersions or sols, in liquid phase.
The particular markers are well known by those skilled in the art. Known in
particular are colored or fluorescent particular markers, such as colloidal gold,
particles of colored latex, fluorescent latex particles and particles conjugated to
avidin or streptavidin, for example.
Among the markers enabling direct observation by the naked eye, we can
also cite dextran-type markers (Hansen T.M., IVD Technology 4, 35-40, 2003).
The binding reagent is then conjugated to a dextran chain (polysaccharide
derivative) bearing fluorophores.
The binding reagents are conjugated to the visible and/or measurable
marker according to techniques well known by those skilled in the art.
In one preferred embodiment of the invention, the detection area of the
capillary action means comprises a third reagent arranged downstream of the
second analyte-specific antibody, and downstream of the analyte, or of the
analogue of the analyte, in relation to the direction of capillary action. This third
reagent makes it possible to have a positive control so as to ensure effective
capillary action of the liquid sample from the deposit area to the detection area of
the capillary action means.
This third reagent is permanently immobilized in the detection area of the
capillary action means.
20

It may involve, for example, an antibody binding itself to the first analyte-
specific antibody conjugated to the marker. In this case, this third reagent makes it
possible to verify migration of the first analyte-specific antibody conjugated to the
marker, to the detection area of the capillary action means. Alternatively, this third
reagent is independent of the analyte and simply enables verification of the action
of the liquid sample to the detection area.
The invention is described in more detail in reference to the following
figures:
Figures
Figure 1: Signal/concentration curve of the analyte for an immunological
assay through a sandwich test
Figure 2: Signal/concentration curve of the analyte for an immunological
assay through a competition test
Figure 3: Device for simultaneous assay of an analyte through a test
according to the present invention
Figure 4: Rapid test device according to the present invention, comprising
an immunochromatographic test strip in a case
Figure 5: Immunochromatographic test strip for hCG detection
Figure 6: Result of the test according to Figure 5 in case of weak analyte
concentration
Figure 7: Result of the test according to Figure 5 in case of a strong analyte
concentration
Figure 1 shows the signal/concentration curve obtained for an
immunological assay through a sandwich test. The curve obtained is a curve of the
Gauss curve type, which shows that to a given signal (S) correspond two possible
21

concentrations of the analyte (C1 and C2), one weak (C1) and the other strong
(C2) during reading of the result at a defined time.
Figure 2 shows a signal/concentration curve for an assay through
competition. One observes the obtaining of two different signals (S1 and S2) for
two concentrations (C1 and C2) of the analyte to be assayed. However, one
observes that the signal is extinct at relatively low concentrations of the analyte.
Figure 3 shows a device for simultaneous assay of an analyte according to
the present invention, the view A) presenting the device without gripping support
and view B), the device comprising a gripping support.
View 3A shows the device comprising a capillary action means (1)
comprising, in the direction of capillary action (2):
a) a deposit or reception area (3) of the sample on a first capillary
material 20;
b) a first analyte-specific antibody (4), conjugated to a visible and/or
measurable marker, which is free to migrate through capillary action when wet in
the capillary action means (1); this first marked antibody is deposited, dry and free,
on a second capillary material 21, in continual capillary circulation with the first
capillary material 20;
c) an analyte-detection area (5) comprising successively, in the
direction of capillary action (2), on one hand a second immobilized analyte-specific
antibody (6), and on the other hand the analyte (7), or an analogue of the analyte,
immobilized; the second antibody and the analyte (or the analogue of the analyte)
are disposed or deposited on a third capillary material, in continual capillary
circulation with the second capillary material 21;
View B) shows the capillary action means (1) integrated into a gripping
support (8) provided with at least one observation window (9) making it possible to
observe the detection area (5), and an opening 23 for collecting, depositing or
receiving the liquid sample.
22

Examples
Pregnancy test (detection in urine of the choriogonadotropin hormone, or
hCG)
Figure 4 shows an external view of a rapid test of the case type wherein is
inserted a chromatographic test strip according to the present invention.
The test strip 1 contains an anti (3-hCG monoclonal antibody 4 marked with
colloidal gold, deposited on the glass fiber 21 and dehydrated (conjugated). This
particular marker is dissolved by the liquid sample when it is deposited in the
sample well (S), then successively comes into contact, through migration on the
test strip, with a first area containing a fixed anti-hCG polyclonal antibody (T1), a
second area containing fixed hCG (T2), and a third area containing a polyclonal
goat anti-mouse immunoglobulin antibody (C), see Figure 5.
In case of absence (or very weak concentration) of the hCG hormone in the
deposited sample, practically no visible reaction will occur in the area T1, while a
line will appear in the area T2 and the area C (Figure 6).
In case of a very strong hCG concentration in the sample, the reaction in
the area T1 will be very weak or nonexistent (due to the "hook" effect previously
described); no visible reaction will take place in the area T2, because nearly all of
the anti p-hCG antibody marked with colloidal gold having reacted with the analyte
(hCG) of the sample, is no longer available to react with the analyte (or any
analogue of the analyte), and the area C will be positive (Figure 7).
This system therefore makes it possible to effectively differentiate
interpretation of the result in case of a low analyte concentration (2 positive lines:
T2 + C) or a strong analyte concentration (1 positive line: C). Moreover, the lines
will appear in different places (T1 or T2).
The table below summarizes the results obtained in the detection area (T1,
T2 and C) according to the analyte concentration in the sample with the help of a
visual reading of the test.
23

hCG
Concentration
(mlU/ml) 0 5 50 00 .103 .104 o5 .105
Line T1 /- + + + + +
Line T2 + + + + + + +
Line C + + + + + + + + +
Table 1: Results of visual reading of the test according to the hCG
concentration in the sample.
In addition to a visual interpretation of the results, it is entirely possible to
perform a reading using a machine, which is then able to provide a quantitative or
semi-quantitative result of the analyte concentration, without prior dilution of the
sample and without using concentration ranges. Indeed, depending on the
concentration area, the results obtained in the detection area are different and the
interpretation of this difference makes it possible, after calibration or by visual
observation, to quantify the analyte concentrations.
24

We Claim:
1. Device for determining an analyte in a liquid sample, comprising:
- a capillary action means (1), involving lateral migration, defining a
reference capillary direction and comprising a liquid sample deposit area (3), and
an analyte-detection area (5), disposed downstream of said deposit area,
- a first analyte-specific binding reagent (4), conjugated to a visible and/or
measurable marker, which is free to migrate when wet, by means of capillary
action in the capillary action means (1) along the reference direction,
- a second analyte-specific binding reagent (6), immobilized in the detection
area,
characterized in that the detection area (5) comprises the analyte (7), or an
analogue of the analyte, which is immobilized and disposed at a distance from the
second specific binding reagent (6).
2. Device according to claim 1, characterized in that it comprises a liquid
sample capture member, independent from the capillary action means, able to be
brought into contact with the deposit area, for a flow of said sample in said deposit
area.
3. Device according to claim 1, characterized in that the capillary action
means (1) comprises a deposit area (4) of the first binding reagent, dry and free, in
or on said capillary action means.
4. Device according to claim 1, characterized in that the deposit area of the
first binding reagent is merged with the sample deposit area (3), or is disposed
downstream of the latter, but upstream of the detection area (5).
5. Device according to claim 1, characterized in that in the detection area (5),
the analyte (7), or the analogue of the analyte, is disposed upstream or
downstream in relation to the second specific binding reagent.
6. Device according to claim 1, characterized in that the second specific
binding reagent (6), and/or the analyte (7), or the analogue of the analyte, are
25

disposed on the capillary action means along a line transverse to the reference
direction.
7. Device according to claim 1, characterized in that the capillary action
means comprises a control area (c), downstream of the detection area (5).
8. Method for implementing a device according to any of claims 1 to 7,
characterized in that:

- the capillary action means of the liquid sample is disposed in the deposit
area (20),
- one waits a sufficient time for the migration through capillary action of the
liquid sample,
- one observes, in the detection area, the extent to which, on one hand the
first specific binding reagent (4) complexed with the analyte attaches itself to the
second specific binding reagent, obtaining a first signal, and on the other hand the
first non-complexed binding reagent attaches itself to the analyte, obtaining a
second signal,
- the analyte is determined from the first and second signals.

9. Method according to claim 8, characterized in that the quantity of the first
binding reagent (4) is greater than the quantity of the analyte present in the liquid
sample, or the number of complexing sites present in said liquid sample.
10. Method according to claim 8, characterized in that a weak analyte
concentration is detected by the absence of the first signal and the presence of the
second signal.
11. Method according to claim 8, characterized in that a strong analyte
concentration is detected by the absence of both signals.
Dated this the 14th day of February, 2008

26

The invention relates to a device for determining an analyte in a liquid sample. The inventive
device consists of: a capillary action means (1), involving lateral migration, defining a
reference capillary action direction and comprising a liquid sample deposit area (3) and an
analyte-detection area (5) which is disposed downstream of the deposit area; a first analyte-specific
binding reagent (4) which is conjugated to a visible and/or measurable marker and
which is free to migrate when wet by means of capillary action in the above-mentioned
capillary action means (1) along the reference direction; and a second analyte-specific
binding reagent (6) which is immobilised in the detection area. The invention is characterised
in that the detection area (5) comprises the analyte (7) or an analogue of the analyte, which is
immobilised and disposed at a distance from the second specific binding reagent (6).

Documents

Orders

Section Controller Decision Date

Application Documents

# Name Date
1 652-KOLNP-2008-RELEVANT DOCUMENTS [09-09-2021(online)].pdf 2021-09-09
1 abstract-00652-kolnp-2008.jpg 2011-10-07
2 652-KOLNP-2008-RELEVANT DOCUMENTS [03-03-2020(online)].pdf 2020-03-03
2 652-KOLNP-2008-TRANSLATED COPY OF PRIORITY DOCUMENT.pdf 2011-10-07
3 652-KOLNP-2008-RELEVANT DOCUMENTS [08-03-2019(online)].pdf 2019-03-08
3 652-KOLNP-2008-PCT REQUEST FORM.pdf 2011-10-07
4 652-KOLNP-2008-IntimationOfGrant25-07-2018.pdf 2018-07-25
4 652-KOLNP-2008-GFA.pdf 2011-10-07
5 652-KOLNP-2008-PatentCertificate25-07-2018.pdf 2018-07-25
5 652-KOLNP-2008-FORM 3-1.1.pdf 2011-10-07
6 652-kolnp-2008-form 18.pdf 2011-10-07
6 652-KOLNP-2008-Amendment Of Application Before Grant - Form 13 [14-06-2018(online)].pdf 2018-06-14
7 652-KOLNP-2008-CORRESPONDENCE OTHERS-1.2.pdf 2011-10-07
7 652-KOLNP-2008-AMMENDED DOCUMENTS [14-06-2018(online)].pdf 2018-06-14
8 652-KOLNP-2008-MARKED COPIES OF AMENDEMENTS [14-06-2018(online)].pdf 2018-06-14
8 652-KOLNP-2008-CORRESPONDENCE OTHERS 1.1.pdf 2011-10-07
9 00652-kolnp-2008-international search report.pdf 2011-10-07
9 652-KOLNP-2008-Written submissions and relevant documents (MANDATORY) [14-06-2018(online)].pdf 2018-06-14
10 00652-kolnp-2008-international publication.pdf 2011-10-07
10 652-KOLNP-2008-HearingNoticeLetter.pdf 2018-04-26
11 00652-kolnp-2008-form 5.pdf 2011-10-07
11 652-KOLNP-2008-ABSTRACT [17-10-2017(online)].pdf 2017-10-17
12 00652-kolnp-2008-form 3.pdf 2011-10-07
12 652-KOLNP-2008-AMENDED DOCUMENTS [17-10-2017(online)].pdf 2017-10-17
13 00652-kolnp-2008-form 2.pdf 2011-10-07
13 652-KOLNP-2008-Changing Name-Nationality-Address For Service [17-10-2017(online)].pdf 2017-10-17
14 00652-kolnp-2008-form 1.pdf 2011-10-07
14 652-KOLNP-2008-CLAIMS [17-10-2017(online)].pdf 2017-10-17
15 00652-kolnp-2008-drawings.pdf 2011-10-07
15 652-KOLNP-2008-COMPLETE SPECIFICATION [17-10-2017(online)].pdf 2017-10-17
16 00652-kolnp-2008-description complete.pdf 2011-10-07
16 652-KOLNP-2008-FER_SER_REPLY [17-10-2017(online)].pdf 2017-10-17
17 652-KOLNP-2008-FORM 3 [17-10-2017(online)].pdf 2017-10-17
17 00652-kolnp-2008-correspondence others.pdf 2011-10-07
18 00652-kolnp-2008-claims.pdf 2011-10-07
18 652-KOLNP-2008-PETITION UNDER RULE 137 [17-10-2017(online)].pdf 2017-10-17
19 00652-kolnp-2008-abstract.pdf 2011-10-07
19 652-KOLNP-2008-PETITION UNDER RULE 137 [17-10-2017(online)].pdf_9.pdf 2017-10-17
20 652-KOLNP-2008-FER.pdf 2017-01-17
20 652-KOLNP-2008-RELEVANT DOCUMENTS [17-10-2017(online)].pdf 2017-10-17
21 Form 4 [04-07-2017(online)].pdf 2017-07-04
22 652-KOLNP-2008-FER.pdf 2017-01-17
22 652-KOLNP-2008-RELEVANT DOCUMENTS [17-10-2017(online)].pdf 2017-10-17
23 00652-kolnp-2008-abstract.pdf 2011-10-07
23 652-KOLNP-2008-PETITION UNDER RULE 137 [17-10-2017(online)].pdf_9.pdf 2017-10-17
24 652-KOLNP-2008-PETITION UNDER RULE 137 [17-10-2017(online)].pdf 2017-10-17
24 00652-kolnp-2008-claims.pdf 2011-10-07
25 652-KOLNP-2008-FORM 3 [17-10-2017(online)].pdf 2017-10-17
25 00652-kolnp-2008-correspondence others.pdf 2011-10-07
26 00652-kolnp-2008-description complete.pdf 2011-10-07
26 652-KOLNP-2008-FER_SER_REPLY [17-10-2017(online)].pdf 2017-10-17
27 00652-kolnp-2008-drawings.pdf 2011-10-07
27 652-KOLNP-2008-COMPLETE SPECIFICATION [17-10-2017(online)].pdf 2017-10-17
28 00652-kolnp-2008-form 1.pdf 2011-10-07
28 652-KOLNP-2008-CLAIMS [17-10-2017(online)].pdf 2017-10-17
29 00652-kolnp-2008-form 2.pdf 2011-10-07
29 652-KOLNP-2008-Changing Name-Nationality-Address For Service [17-10-2017(online)].pdf 2017-10-17
30 00652-kolnp-2008-form 3.pdf 2011-10-07
30 652-KOLNP-2008-AMENDED DOCUMENTS [17-10-2017(online)].pdf 2017-10-17
31 00652-kolnp-2008-form 5.pdf 2011-10-07
31 652-KOLNP-2008-ABSTRACT [17-10-2017(online)].pdf 2017-10-17
32 00652-kolnp-2008-international publication.pdf 2011-10-07
32 652-KOLNP-2008-HearingNoticeLetter.pdf 2018-04-26
33 00652-kolnp-2008-international search report.pdf 2011-10-07
33 652-KOLNP-2008-Written submissions and relevant documents (MANDATORY) [14-06-2018(online)].pdf 2018-06-14
34 652-KOLNP-2008-CORRESPONDENCE OTHERS 1.1.pdf 2011-10-07
34 652-KOLNP-2008-MARKED COPIES OF AMENDEMENTS [14-06-2018(online)].pdf 2018-06-14
35 652-KOLNP-2008-AMMENDED DOCUMENTS [14-06-2018(online)].pdf 2018-06-14
35 652-KOLNP-2008-CORRESPONDENCE OTHERS-1.2.pdf 2011-10-07
36 652-kolnp-2008-form 18.pdf 2011-10-07
36 652-KOLNP-2008-Amendment Of Application Before Grant - Form 13 [14-06-2018(online)].pdf 2018-06-14
37 652-KOLNP-2008-PatentCertificate25-07-2018.pdf 2018-07-25
37 652-KOLNP-2008-FORM 3-1.1.pdf 2011-10-07
38 652-KOLNP-2008-IntimationOfGrant25-07-2018.pdf 2018-07-25
38 652-KOLNP-2008-GFA.pdf 2011-10-07
39 652-KOLNP-2008-RELEVANT DOCUMENTS [08-03-2019(online)].pdf 2019-03-08
39 652-KOLNP-2008-PCT REQUEST FORM.pdf 2011-10-07
40 652-KOLNP-2008-TRANSLATED COPY OF PRIORITY DOCUMENT.pdf 2011-10-07
40 652-KOLNP-2008-RELEVANT DOCUMENTS [03-03-2020(online)].pdf 2020-03-03
41 abstract-00652-kolnp-2008.jpg 2011-10-07
41 652-KOLNP-2008-RELEVANT DOCUMENTS [09-09-2021(online)].pdf 2021-09-09

Search Strategy

1 SEARCH_03-01-2017.pdf

ERegister / Renewals

3rd: 27 Sep 2018

From 23/08/2008 - To 23/08/2009

4th: 27 Sep 2018

From 23/08/2009 - To 23/08/2010

5th: 27 Sep 2018

From 23/08/2010 - To 23/08/2011

6th: 27 Sep 2018

From 23/08/2011 - To 23/08/2012

7th: 27 Sep 2018

From 23/08/2012 - To 23/08/2013

8th: 27 Sep 2018

From 23/08/2013 - To 23/08/2014

9th: 27 Sep 2018

From 23/08/2014 - To 23/08/2015

10th: 27 Sep 2018

From 23/08/2015 - To 23/08/2016

11th: 27 Sep 2018

From 23/08/2016 - To 23/08/2017

12th: 27 Sep 2018

From 23/08/2017 - To 23/08/2018

13th: 27 Sep 2018

From 23/08/2018 - To 23/08/2019

14th: 31 Jul 2019

From 23/08/2019 - To 23/08/2020

15th: 19 Aug 2020

From 23/08/2020 - To 23/08/2021

16th: 18 Aug 2021

From 23/08/2021 - To 23/08/2022